Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Csilla Sipeky

4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation

scientific article published on 01 October 2019

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

scientific article published on 24 June 2020

Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome

scientific article published on 7 October 2007

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scientific article published on 11 June 2018

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

scientific article published on 11 June 2018

Genetic biomarkers to guide poly (ADP-ribose) polymerase inhibitor precision treatment of prostate cancer

scientific article published on 06 October 2020

Genome-wide association study of prostate cancer-specific survival

scientific article published on 25 August 2015

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

scientific article published on 3 January 2018

Haplogroup analysis of vitamin-K epoxide reductase (VKORC1) gene: novel element in the optimization of anticoagulant therapy

scientific article published in September 2008

High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature

scientific article published on 05 May 2013

Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation

scientific article published on 08 August 2019

Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view

scientific article published on 02 December 2019

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

scientific article published on 10 January 2018

Possible role of selected IGR and SLC22A4/SLC22A5 loci in development of inflammatory bowel diseases

scientific article

Prevalence of SLC22A4 1672T and SLC22A5 -207C combination defined TC haplotype in Hungarian ulcerative colitis patients

scientific article published on 27 March 2007

ShAn: An easy-to-use tool for interactive and integrated variant annotation

scientific article published on 07 July 2020

Significance of thiopurine s-methyltransferase gene test in a clinical case

scientific article published in February 2012

The effect of sample size on polygenic hazard models for prostate cancer

scientific article published on 08 June 2020

Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples.

scientific article published in June 2009

[Mitochondrial DNA and its mutations: new advances in a new field]

scientific article published on 01 May 2007